Loading...
NPI 1528039484 · Scottsdale, AZ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Mayo Clinic Arizona is a clinical medical laboratory provider located in Scottsdale, Arizona. This profile covers 297 Medicare and 20 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Mayo Clinic Arizona |
| Address | 13400 E Shea Blvd |
| City | Scottsdale |
| State | AZ |
| ZIP | 85259 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | January 30, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.1M |
| Medicaid | $76.8K |
MAYO CLINIC ARIZONA is registered as a Clinical Medical Laboratory and has been enumerated since 2006-01-30 (~20 years ago), indicating long-standing participation in Medicare and Medicaid laboratory billing. Its lifetime Medicare revenue is $3.1M versus $76.8K in Medicaid, so its commercial scale is overwhelmingly Medicare-driven and it functions operationally as a Medicare-focused lab provider.
Medicare revenue is dispersed across many test codes: the top three Medicare codes account for 24.3% of the provider’s Medicare revenue, led by 36415 at $218K (10.3%), followed by 88305 at $158.5K (7.5%) and 83521 at $135.7K (6.4%). This mix shows substantial volume in phlebotomy and routine/specialty laboratory assays rather than reliance on a single high-revenue procedure.
Medicaid billing is highly concentrated: the top three Medicaid codes account for 74.3% of the provider’s Medicaid revenue, driven by G0480 at $25.9K (33.3%), 80197 at $20.4K (26.3%), and 86635 at $11.4K (14.7%). That concentration suggests the provider’s small Medicaid footprint is focused on a narrow set of definitive drug testing, tacrolimus quantitation, and fungal serology services.
The service-line profile is consistent with an integrated clinical lab that handles very high-volume specimen collection and routine panels plus specialized immunology, oncology, and transplant monitoring assays. High Medicare volumes for 36415 (phlebotomy), 85025/80053/80048 (CBCs and metabolic panels), and specialized assays such as 83521 (free light chains), 82610 (cystatin C), and 84165 (SPEP) indicate capacity for both routine outpatient testing and downstream specialty diagnostics (pathology codes 88305/88341/88342 present interpretive work).
On competitive standing for Medicare, the provider registers as a high-volume national participant on multiple codes: 36415 ranks #101 of 86467 providers nationally (100th percentile; notably above typical national volume) and several specialized assays rank in very high percentiles (for example, 82610 ranks #6 of 209 nationally (98th percentile; extreme outlier) and 88341/88342/88112 rank in the top percentiles). These rankings characterize the lab as a major national operator for sample collection and select high-complexity assays/pathology interpretations.
By contrast, the provider’s in-state Medicaid footprint is modest and concentrated. G0480 ranks #42 of 61 providers in-state (32th percentile) and 80197 ranks #6 of 13 providers in-state (58th percentile), suggesting the practice is not a dominant Medicaid lab in Arizona and competes more narrowly on a few reimbursed services.
Several statistical outlier signals point to structural capacity in specific test areas: 82610 is labeled an "extreme outlier, far above typical national volume," while 36415 and multiple pathology/immunoassay codes are described as "notably above typical national volume." These labels support an interpretation that the provider has unusually large throughput for certain assays (cystatin C, high-volume phlebotomy) and pathology services that could reflect referral relationships with specialty clinics.
For payers and network managers, the profile implies two clear implications: contracting and utilization management should prioritize Medicare relationships because Medicare accounts for the bulk of revenue ($3.1M vs. $76.8K), and any effort to expand Medicaid revenue would likely require broadening the array of services billed to Medicaid beyond the current high-concentration trio (G0480, 80197, 86635). Given the provider’s long tenure (~20 years) and its mix of high-volume routine testing plus specialty assays, there is operational capacity to scale Medicaid work if payer arrangements and referral flows are adjusted.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
297 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 27,250 | $10 | $218K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 3,230 | $50 | $158.5K |
| 83521 | The lab analyst performs a chemistry test to measure the level of each immunoglobulin light chain, kappa or lambda, in a serum specimen. A common lab method for this test is turbidimetry, which uses… | 7,980 | $20 | $135.7K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 16,820 | $10 | $134.6K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 7,660 | $20 | $122.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 11,870 | $10 | $118.7K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 1,740 | $60 | $111.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 3,690 | $30 | $107K |
| 82784 | The lab analyst performs the technical lab test to analyze the concentration of a particular gamma globulin in the specimen. The analyst may test for immunoglobulin A, immunoglobulin D,… | 11,640 | $10 | $104.8K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 1,190 | $70 | $85.5K |
Showing 1–10 of 297
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 297 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
297 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87150 | 3 | 10 | 70 | $30 | $1.6M |
| 87798 | 9 | 10 | 650 | $30 | $553.2K |
| 86003 | 3 | 10 | 48,520 | $10 | $302K |
| 88381 | 9 | 10 | 390 | $120 | $286.2K |
| 82784 | 3 | 10 | 11,640 | $10 | $197.3K |
| 83521 | 3 | 10 | 8,690 | $20 | $174.5K |
| 86147 | 3 | 10 | 6,020 | $20 | $109K |
| 86146 | 3 | 10 | 5,000 | $20 | $85.9K |
| 87529 | 4 | 10 | 730 | $30 | $83.2K |
| 87799 | 3 | 10 | 2,480 | $40 | $82.2K |
Showing 1–10 of 297
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
20 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 380 | $70 | $25.9K |
| 80197 | The lab analyst performs the technical lab test to analyze a specimen to quantitate the total amount of tacrolimus present, which is an immunosuppressant drug patients often use to prevent rejection… | 5,110 | $1 | $20.4K |
| 86635 | The lab analyst performs an immunoassay to evaluate the patient’s blood or cerebrospinal fluid for antibodies to the fungus Coccidioides. | 1,630 | $10 | $11.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 320 | $20 | $6K |
| 82610 | The lab analyst performs the technical lab test to measure the amount of a protein, typically in the blood, called cystatin C. | 300 | $20 | $5K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 750 | $10 | $3.7K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 1,140 | $1 | $2.3K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 1,890 | $1 | $1.9K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 30 | $10 | $240 |
| 81001 | Urinalysis is used to detect substances or cellular material in the urine associated with different metabolic and kidney disorders. It is used to detect urinary tract infections (UTI) and other… | 170 | $1 | $170 |
Showing 1–10 of 20
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
20 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 42 | 60 | 1,000 | $40 | $331.5K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 138 | 200 | 3,310 | $10 | $191.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 54 | 100 | 380 | $10 | $137.9K |
| 80197 | The lab analyst performs the technical lab test to analyze a specimen to quantitate the total amount of tacrolimus present, which is an immunosuppressant drug patients often use to prevent rejection… | 6 | 10 | 2,010 | $10 | $55.8K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 75 | 90 | 220 | $1 | $43.7K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 205 | 250 | 440 | $1 | $35.8K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 191 | 280 | 2,520 | $1 | $30.3K |
| 82784 | The lab analyst performs the technical lab test to analyze the concentration of a particular gamma globulin in the specimen. The analyst may test for immunoglobulin A, immunoglobulin D,… | 19 | 20 | 1,110 | $1 | $29.8K |
| 86635 | The lab analyst performs an immunoassay to evaluate the patient’s blood or cerebrospinal fluid for antibodies to the fungus Coccidioides. | 7 | 30 | 790 | $10 | $25.3K |
| 82570 | The lab analyst measures the amount of creatinine, in a patient specimen, other than blood. Creatinine is the waste material generated by the muscle tissue produced from the breakdown of creatine… | 48 | 60 | 780 | $1 | $18.1K |
Showing 1–10 of 20
Other providers in the same ZIP code as Mayo Clinic Arizona, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Dsf Of The Valley, Inc | AZ | Durable Medical Equipment & Medical Supplies | $0 | $27.4M |
| Januario Castro | AZ | Hematology & Oncology Physician | $1.6M | $0 |
| Cassandra Moore | AZ | Hematology & Oncology Physician | $1.5M | $0 |
| Mohamad Sonbol | AZ | Hematology & Oncology Physician | $1.5M | $0 |
| Ba Nguyen | AZ | Diagnostic Radiology Physician | $1.4M | $0 |
| Felipe Martinez | AZ | Nuclear Medicine Physician | $1.3M | $0 |
| Karen Anderson | AZ | Hematology & Oncology Physician | $1.2M | $0 |
| Mazie Tsang | AZ | Hematology & Oncology Physician | $1.2M | $0 |
| Vinicius Ernani | AZ | Hematology & Oncology Physician | $1.2M | $0 |
| Daniel Ahn | AZ | Hematology & Oncology Physician | $1.2M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.